Tuesday, February 12, 2008
NHLBI Study: What’s Next?
Last week The National Heart, Lung, and Blood Institute (NHLBI) halted a treatment regimen that was part of a large trial assessing treatment goals for those with both type 2 diabetes and very high risk of cardiovascular disease. Patients had been divided into two groups with different blood sugar goals:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment